These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8984765)

  • 41. [Differentiated cancer of the thyroid: prognostic aspects].
    Veroux P; Fazzi C; Cavallaro A; Veroux M; Cannizzaro MA
    Chir Ital; 1997; 49(1-2):37-41. PubMed ID: 12743874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Identification and validation of prognostic factors in differentiated thyroid carcinoma].
    Gómez Arnaiz N; Gómez Sáez IM; Sahún de la Vega M; Abós R; Villabona Artero C; Soler Ramón J
    Med Clin (Barc); 1997 Jan; 108(2):45-9. PubMed ID: 9064416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Iodine deficiency and thyroid nodular pathology--epidemiological and cancer characteristics in different populations: Portugal and South Africa.
    Santos JE; Kalk WJ; Freitas M; Marques Carreira I; Castelo Branco M
    BMC Res Notes; 2015 Jul; 8():284. PubMed ID: 26126625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer.
    Yang L; Shen W; Sakamoto N
    J Clin Oncol; 2013 Feb; 31(4):468-74. PubMed ID: 23270002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative characteristics of thyroid cancer morbidity based on clinical data].
    Shevchenko SI; Sivozhelezov AV; Shevchenko RS
    Klin Khir (1962); 1993; (7-8):39-41. PubMed ID: 8139192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Primary cancer of the thyroid: natural history and therapy principles].
    Veroux P; Fazzi C; Nicosia AS; Veroux M; Cannizzaro MA
    Chir Ital; 1997; 49(1-2):15-27. PubMed ID: 12743871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Well-differentiated thyroid carcinoma: factors predicting recurrence and survival.
    Lim LH; Soo KC; Chong YK; Gao F; Hong GS; Lim TH
    Singapore Med J; 2002 Sep; 43(9):457-62. PubMed ID: 12568423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical features of bone metastases resulting from thyroid cancer: a review of 28 patients over a 20-year period.
    Do MY; Rhee Y; Kim DJ; Kim CS; Nam KH; Ahn CW; Cha BS; Kim KR; Lee HC; Park CS; Lim SK
    Endocr J; 2005 Dec; 52(6):701-7. PubMed ID: 16410661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyroid malignancies: a New Zealand South Island thyroid clinic experience 1995-2006.
    Brownlie B; Mercer P; Turner J; Allison R
    N Z Med J; 2008 Aug; 121(1279):36-45. PubMed ID: 18709046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Population-based outcomes for pediatric thyroid carcinoma.
    Shapiro NL; Bhattacharyya N
    Laryngoscope; 2005 Feb; 115(2):337-40. PubMed ID: 15689762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Chronological changes in the representation of papillary and follicular carcinomas in our patient group 1960-1993].
    Nĕmec J; Zamrazil V; Dvorák J; Zeman V
    Bratisl Lek Listy; 1995 Nov; 96(11):619-21. PubMed ID: 8624743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changing clinical characteristics of thyroid carcinoma at a single center from Turkey: before and after the Chernobyl disaster.
    Ozdemir D; Dagdelen S; Kiratli P; Tuncel M; Erbas B; Erbas T
    Minerva Endocrinol; 2012 Sep; 37(3):267-74. PubMed ID: 22766893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Multiple primary malignancies associated with thyroid cancer].
    Shinozaki N; Sakamoto A; Kasai N; Uchida M; Sakurai K
    Gan No Rinsho; 1983 Oct; 29(12):1385-91. PubMed ID: 6645058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Classification and epidemiology of thyroid tumors].
    Klein M; Aubert V; Weryha G; Leclère J
    Rev Prat; 1996 Dec; 46(19):2288-95. PubMed ID: 8978185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland.
    Kilfoy BA; Devesa SS; Ward MH; Zhang Y; Rosenberg PS; Holford TR; Anderson WF
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1092-100. PubMed ID: 19293311
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thyroid cancer in Vaud, Switzerland: an update.
    Levi F; Randimbison L; Te VC; La Vecchia C
    Thyroid; 2002 Feb; 12(2):163-8. PubMed ID: 11916286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Descriptive epidemiology of thyroid cancer in Osaka.
    Hanai A; Fujimoto I
    Natl Cancer Inst Monogr; 1982; 62():201-6. PubMed ID: 7167190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thyroid cancers in Ibadan, Nigeria.
    Thomas JO; Ogunbiyi JO
    East Afr Med J; 1995 Apr; 72(4):231-3. PubMed ID: 7621758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does life along the sea carry greater risk of thyroid cancer?
    Poljak NK; Kontić M; Colović Z; Jeroncić I; Russo A; Mulić R
    Coll Antropol; 2012 Jun; 36(2):431-9. PubMed ID: 22856227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Occult papillary thyroid carcinoma: prevalence at autopsy in Turkish people.
    Tanriover O; Comunoglu N; Eren B; Comunoglu C; Turkmen N; Dogan M; Gündogmus UN
    Eur J Cancer Prev; 2011 Jul; 20(4):308-12. PubMed ID: 21464719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.